ResearchMoz added Latest Research Report titled ” Bacterial Pneumonia – Pipeline Review, H2 2016 ” to it’s Large Report database.
Bacterial Pneumonia – Pipeline Review, H2 2016
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Pneumonia Pipeline Review, H2 2016, provides an overview of the Bacterial Pneumonia (Infectious Disease) pipeline landscape.
Bacterial pneumonia is an infection in one or both lungs. The bacteria cause the lungs air sacs (alveoli) to become inflamed and engorged with pus, fluid, and cellular debris. This often impairs the bodys ability to exchange oxygen and carbon dioxide. Predisposing factors are age, long-term users of immunosuppressant drugs, chronic obstructive pulmonary disease (COPD) patients who use inhaled corticosteroids for lengthy periods and smokers. Symptoms include cough with yellow, green, or blood-tinged mucus, headache, muscle pain, breathlessness or rapid breathing, lethargy and confusion.
Download free Sample PDF report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=905716
Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Bacterial Pneumonia Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Bacterial Pneumonia (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Bacterial Pneumonia (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Pneumonia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 7, 8, 13, 2, 30, 12 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Preclinical and Discovery stages comprises 1, 1, 9 and 6 molecules, respectively.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Contents
Table of Contents 2
Bacterial Pneumonia Overview 6
Therapeutics Development 7
Bacterial Pneumonia – Therapeutics under Development by Companies 9
Bacterial Pneumonia – Therapeutics under Investigation by Universities/Institutes 12
Bacterial Pneumonia – Pipeline Products Glance 13
Bacterial Pneumonia – Products under Development by Companies 17
Bacterial Pneumonia – Products under Investigation by Universities/Institutes 21
Bacterial Pneumonia – Companies Involved in Therapeutics Development 22
Bacterial Pneumonia – Therapeutics Assessment 65
Drug Profiles 75
Bacterial Pneumonia – Dormant Projects 185
Bacterial Pneumonia – Discontinued Products 190
Bacterial Pneumonia – Product Development Milestones 191
List of Tables
Number of Products under Development for Bacterial Pneumonia, H2 2016 17
Number of Products under Development for Bacterial Pneumonia – Comparative Analysis, H2 2016 18
Number of Products under Development by Companies, H2 2016 19
Number of Products under Development by Companies, H2 2016 (Contd..1) 20
Number of Products under Development by Companies, H2 2016 (Contd..2) 21
Number of Products under Investigation by Universities/Institutes, H2 2016 22
Comparative Analysis by Late Stage Development, H2 2016 23
Comparative Analysis by Clinical Stage Development, H2 2016 24
Comparative Analysis by Early Stage Development, H2 2016 25
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/